- Home
- MTEK vs RDHL Comparison
MTEK vs RDHL Comparison
Compare MTEK & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEK
- RDHL
- Stock Information
- Founded
- MTEK 2008
- RDHL 2009
- Country
- MTEK Israel
- RDHL Israel
- Employees
- MTEK N/A
- RDHL N/A
- Industry
- MTEK
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- MTEK
- RDHL Health Care
- Exchange
- MTEK Nasdaq
- RDHL Nasdaq
- Market Cap
- MTEK 24.0M
- RDHL 3.9M
- IPO Year
- MTEK 2022
- RDHL N/A
- Fundamental
- Price
- MTEK $3.39
- RDHL $1.50
- Analyst Decision
- MTEK
- RDHL
- Analyst Count
- MTEK 0
- RDHL 0
- Target Price
- MTEK N/A
- RDHL N/A
- AVG Volume (30 Days)
- MTEK 96.6K
- RDHL 88.3K
- Earning Date
- MTEK 09-05-2025
- RDHL 09-05-2025
- Dividend Yield
- MTEK N/A
- RDHL N/A
- EPS Growth
- MTEK N/A
- RDHL N/A
- EPS
- MTEK N/A
- RDHL N/A
- Revenue
- MTEK $6,078,953.00
- RDHL $9,550,000.00
- Revenue This Year
- MTEK N/A
- RDHL $381.91
- Revenue Next Year
- MTEK N/A
- RDHL N/A
- P/E Ratio
- MTEK N/A
- RDHL N/A
- Revenue Growth
- MTEK 50.80
- RDHL 157.62
- 52 Week Low
- MTEK $1.63
- RDHL $1.06
- 52 Week High
- MTEK $6.47
- RDHL $11.70
- Technical
- Relative Strength Index (RSI)
- MTEK 62.63
- RDHL 53.60
- Support Level
- MTEK $3.06
- RDHL $1.22
- Resistance Level
- MTEK $3.32
- RDHL $1.60
- Average True Range (ATR)
- MTEK 0.28
- RDHL 0.08
- MACD
- MTEK 0.06
- RDHL 0.04
- Stochastic Oscillator
- MTEK 95.14
- RDHL 73.68
About MTEK Maris-Tech Ltd.
Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.